Lineage Cell Therapeutics, Inc. (LCTX)

Lineage Cell Therapeutics Market Cap

Lineage Cell Therapeutics has a market cap or net worth of $230.64 million as of July 3, 2025. Its market cap has increased by 34.96% in one year.

• Market Cap: 230.64M
• Enterprise Value: 184.98M
• 1-Year Change: 34.96%
• Ranking: #3638
• Category: Micro-Cap
• Stock Price: $1.01

Market Cap Chart

Since December 1, 1998, Lineage Cell Therapeutics's market cap has increased from $147.40M to $230.64M, an increase of 56.47%. That is a compound annual growth rate of 1.70%.

Market Cap History

Date	Market Cap	% Change
Jul 3, 2025	230.60M	143.25%
Dec 31, 2024	94.80M	-50.29%
Dec 29, 2023	190.70M	-4.12%
Dec 30, 2022	198.90M	-51.84%
Dec 31, 2021	413.00M	56.44%
Dec 31, 2020	264.00M	98.05%
Dec 31, 2019	133.30M	15.01%
Dec 31, 2018	115.90M	-57.51%
Dec 29, 2017	272.80M	-26.90%
Dec 30, 2016	373.20M	-4.09%
Dec 31, 2015	389.10M	25.52%
Dec 31, 2014	310.00M	28.15%
Dec 31, 2013	241.90M	51.38%
Dec 31, 2012	159.80M	-45.26%
Dec 30, 2011	291.90M	-26.38%
Dec 31, 2010	396.50M	181.41%
Dec 31, 2009	140.90M	234.68%
Dec 31, 2008	42.10M	347.87%
Dec 31, 2007	9.40M	54.10%
Dec 29, 2006	6.10M	10.91%
Dec 30, 2005	5.50M	-79.55%
Dec 31, 2004	26.90M	43.09%
Dec 31, 2003	18.80M	-10.05%
Dec 31, 2002	20.90M	-60.79%
Dec 31, 2001	53.30M	-37.37%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	697.81B
Johnson & Johnson	375.08B
AbbVie	337.65B
Novo Nordisk	306.99B
UnitedHealth Group	281.48B
Novartis AG	242.04B
Abbott Laboratories	234.30B
AstraZeneca	219.33B